Strain-Level Differences in Porphyrin Production and Regulation in Propionibacterium acnes Elucidate Disease Associations
- PMID: 27303708
- PMCID: PMC4863617
- DOI: 10.1128/mSphere.00023-15
Strain-Level Differences in Porphyrin Production and Regulation in Propionibacterium acnes Elucidate Disease Associations
Abstract
Propionibacterium acnes is an important skin commensal, but it is also considered a pathogenic factor in several diseases including acne vulgaris, the most common skin disease. While previous studies have revealed P. acnes strain-level differences in health and disease associations, the underlying molecular mechanisms remain unknown. Recently, we demonstrated that vitamin B12 supplementation increases P. acnes production of porphyrins, a group of proinflammatory metabolites important in acne development (D. Kang, B. Shi, M. C. Erfe, N. Craft, and H. Li, Sci. Transl. Med. 7:293ra103, 2015, doi:10.1126/scitranslmed.aab2009). In this study, we compared the porphyrin production and regulation of multiple P. acnes strains. We revealed that acne-associated type IA-2 strains inherently produced significantly higher levels of porphyrins, which were further enhanced by vitamin B12 supplementation. On the other hand, health-associated type II strains produced low levels of porphyrins and did not respond to vitamin B12. Using a small-molecule substrate and inhibitor, we demonstrated that porphyrin biosynthesis was modulated at the metabolic level. We identified a repressor gene (deoR) of porphyrin biosynthesis that was carried in all health-associated type II strains, but not in acne-associated type IA-2 strains. The expression of deoR suggests additional regulation of porphyrin production at the transcriptional level in health-associated strains. Our findings provide one potential molecular mechanism for the different contributions of P. acnes strains to skin health and disease and support the role of vitamin B12 in acne pathogenesis. Our study emphasizes the importance of understanding the role of the commensal microbial community in health and disease at the strain level and suggests potential utility of health-associated P. acnes strains in acne treatment. IMPORTANCE Propionibacterium acnes is a dominant bacterium residing on skin, and it has been thought to play a causal role in several diseases including acne, a common skin disease affecting more than 80% of people worldwide. While specific strains of P. acnes have been associated with either disease or healthy skin, the mechanisms remain unclear. Recently, we showed that vitamin B12 supplementation increased porphyrin production in P. acnes, leading to acne development (D. Kang, B. Shi, M. C. Erfe, N. Craft, and H. Li, Sci. Transl. Med. 7:293ra103, 2015, doi:10.1126/scitranslmed.aab2009). Here, we reveal that the levels of porphyrin production and vitamin B12 regulation are different between acne- and health-associated strains, suggesting a potential molecular mechanism for disease-associated strains in acne pathogenesis and for health-associated strains in skin health. This study highlights the importance of understanding the strain-level differences of the human microbiota in disease pathogenesis. Our findings also suggest the porphyrin biosynthesis pathway as a candidate drug target and use of health-associated strains as potential probiotics in novel acne therapeutics.
Keywords: 5-aminolevulinic acid; Propionibacterium acnes; acne; levulinic acid; porphyrin; strain; vitamin B12.
Figures






Similar articles
-
Porphyrin Production and Regulation in Cutaneous Propionibacteria.mSphere. 2020 Jan 15;5(1):e00793-19. doi: 10.1128/mSphere.00793-19. mSphere. 2020. PMID: 31941813 Free PMC article.
-
Vitamin B12 modulates the transcriptome of the skin microbiota in acne pathogenesis.Sci Transl Med. 2015 Jun 24;7(293):293ra103. doi: 10.1126/scitranslmed.aab2009. Sci Transl Med. 2015. PMID: 26109103 Free PMC article.
-
Pan-genome and comparative genome analyses of propionibacterium acnes reveal its genomic diversity in the healthy and diseased human skin microbiome.mBio. 2013 Apr 30;4(3):e00003-13. doi: 10.1128/mBio.00003-13. mBio. 2013. PMID: 23631911 Free PMC article.
-
Porphyrin metabolisms in human skin commensal Propionibacterium acnes bacteria: potential application to monitor human radiation risk.Curr Med Chem. 2013;20(4):562-8. doi: 10.2174/0929867311320040007. Curr Med Chem. 2013. PMID: 23231351 Free PMC article. Review.
-
Typing of Propionibacterium acnes: a review of methods and comparative analysis.Br J Dermatol. 2015;172(5):1204-9. doi: 10.1111/bjd.13667. Epub 2015 Apr 9. Br J Dermatol. 2015. PMID: 25600912 Review.
Cited by
-
The Skin Microbiota: Balancing Risk and Reward.Cell Host Microbe. 2020 Aug 12;28(2):190-200. doi: 10.1016/j.chom.2020.06.017. Cell Host Microbe. 2020. PMID: 32791112 Free PMC article. Review.
-
Investigating Propionibacterium acnes antibiotic susceptibility and response to bacteriophage in vitro and in vivo.Front Microbiol. 2024 Jun 21;15:1424849. doi: 10.3389/fmicb.2024.1424849. eCollection 2024. Front Microbiol. 2024. PMID: 38974030 Free PMC article.
-
5-α reductase inhibition by Epilobioum fleischeri extract modulates facial microbiota structure.Int J Cosmet Sci. 2022 Aug;44(4):440-452. doi: 10.1111/ics.12777. Epub 2022 Jun 23. Int J Cosmet Sci. 2022. PMID: 35499362 Free PMC article. Clinical Trial.
-
The role of biofilm formation in the pathogenesis and antimicrobial susceptibility of Cutibacterium acnes.Biofilm. 2021 Dec 9;4:100063. doi: 10.1016/j.bioflm.2021.100063. eCollection 2022 Dec. Biofilm. 2021. PMID: 34950868 Free PMC article. Review.
-
Role of Cutaneous Microbiome in Dermatology.Indian J Dermatol. 2023 May-Jun;68(3):303-312. doi: 10.4103/ijd.ijd_560_22. Indian J Dermatol. 2023. PMID: 37529462 Free PMC article.
References
-
- Nagy I, Pivarcsi A, Kis K, Koreck A, Bodai L, McDowell A, Seltmann H, Patrick S, Zouboulis CC, Kemény L. 2006. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect 8:2195–2205. doi:10.1016/j.micinf.2006.04.001. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical